New Products: Mulitplicom's MID and MASTR Kits; Laboratoire Cerba's NIPT; More | GenomeWeb

Belgian company Multiplicom has launched a CE-IVD labeled MID kit for Illumina's MiSeq system as well as three germline mutation detection kits using the company's MASTR technology for maturity onset diabetes of the young, autosomal dominant hypercholesterolemia, and hypertrophic cardiomyopathy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.